CN104546606B - 一种水包油祛妊娠纹霜及其制备方法 - Google Patents
一种水包油祛妊娠纹霜及其制备方法 Download PDFInfo
- Publication number
- CN104546606B CN104546606B CN201410824539.9A CN201410824539A CN104546606B CN 104546606 B CN104546606 B CN 104546606B CN 201410824539 A CN201410824539 A CN 201410824539A CN 104546606 B CN104546606 B CN 104546606B
- Authority
- CN
- China
- Prior art keywords
- striae
- component
- pregnancy
- components
- frost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000035935 pregnancy Effects 0.000 title claims abstract description 91
- 206010040925 Skin striae Diseases 0.000 title claims abstract description 88
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000000605 extraction Methods 0.000 claims abstract description 16
- 240000004246 Agave americana Species 0.000 claims abstract description 15
- 235000008754 Agave americana Nutrition 0.000 claims abstract description 15
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 14
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 10
- 229960001631 carbomer Drugs 0.000 claims abstract description 10
- 239000008367 deionised water Substances 0.000 claims abstract description 10
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 10
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 claims abstract description 9
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 9
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims abstract description 9
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 7
- 229960000458 allantoin Drugs 0.000 claims abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- -1 alcohol phosphate kalium salt Chemical class 0.000 claims description 20
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 14
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 claims description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 9
- 125000005908 glyceryl ester group Chemical group 0.000 claims description 9
- 229940100491 laureth-2 Drugs 0.000 claims description 9
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 9
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 9
- 229940042585 tocopherol acetate Drugs 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 8
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 8
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 8
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 229940057910 shea butter Drugs 0.000 claims description 8
- 238000004945 emulsification Methods 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 238000010583 slow cooling Methods 0.000 claims description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims 1
- 241000167550 Centella Species 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003995 emulsifying agent Substances 0.000 abstract description 6
- 150000005846 sugar alcohols Polymers 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 210000001015 abdomen Anatomy 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 238000010612 desalination reaction Methods 0.000 abstract description 3
- 239000004519 grease Substances 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000003750 conditioning effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 17
- 238000000034 method Methods 0.000 description 12
- 239000000686 essence Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- OJIBJRXMHVZPLV-UHFFFAOYSA-N 2-methylpropyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(C)C OJIBJRXMHVZPLV-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000004177 elastic tissue Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- DIBAKBGYJUCGDL-UHFFFAOYSA-N 2,6-diamino-n-[1-[(2-amino-2-oxoethyl)amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]hexanamide Chemical compound NCCCCC(N)C(=O)NC(C(=O)NCC(N)=O)CC1=CN=CN1 DIBAKBGYJUCGDL-UHFFFAOYSA-N 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- 244000173853 Sanguisorba officinalis Species 0.000 description 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 108010026970 bursopoietin Proteins 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 210000001643 allantois Anatomy 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410824539.9A CN104546606B (zh) | 2014-12-26 | 2014-12-26 | 一种水包油祛妊娠纹霜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410824539.9A CN104546606B (zh) | 2014-12-26 | 2014-12-26 | 一种水包油祛妊娠纹霜及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104546606A CN104546606A (zh) | 2015-04-29 |
CN104546606B true CN104546606B (zh) | 2017-12-29 |
Family
ID=53064395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410824539.9A Active CN104546606B (zh) | 2014-12-26 | 2014-12-26 | 一种水包油祛妊娠纹霜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104546606B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104921983A (zh) * | 2015-05-25 | 2015-09-23 | 广西达庆生物科技有限公司 | 一种孕妇妊娠纹医用生物修复敷料及其制备方法 |
CN106265310A (zh) * | 2016-08-31 | 2017-01-04 | 天津天狮生物发展有限公司 | 预防妊娠纹组合物和妊娠纹霜及其制备方法 |
CN108096097A (zh) * | 2017-12-27 | 2018-06-01 | 广东袋鼠妈妈生物科技有限公司 | 一种小麦胚芽妊娠纹防护弹力霜 |
CN107898734B (zh) * | 2018-01-04 | 2021-08-31 | 上海紫邦生物医药有限公司 | 龙舌兰提取物在制备外用止痒保湿个人护理品中的应用 |
CN108175740B (zh) * | 2018-01-29 | 2020-11-10 | 广东袋鼠妈妈生物科技有限公司 | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 |
CN108158859A (zh) * | 2018-02-02 | 2018-06-15 | 连云港市谭笑生物科技研究所 | 一种身体修护霜 |
CN109044888A (zh) * | 2018-10-19 | 2018-12-21 | 上海纳米技术及应用国家工程研究中心有限公司 | 茶籽油祛妊娠纹滋润霜及其制备方法 |
CN110151624A (zh) * | 2019-06-13 | 2019-08-23 | 广州方媚化妆品有限公司 | 妊娠纹涂抹修复精华乳 |
CN110314127B (zh) * | 2019-08-23 | 2022-06-21 | 杭州千岛湖蓝色天使实业有限公司 | 一种祛妊娠纹精华乳及其制备方法 |
CN112451460A (zh) * | 2020-12-31 | 2021-03-09 | 广州市医康生物科技有限公司 | 一种番红花提取物的提取方法及包含该提取物的祛妊娠纹霜 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152138A (zh) * | 2007-09-29 | 2008-04-02 | 天津盛世恒安科技发展有限公司 | 一种具有祛除妊娠纹功效的化妆制品及其制备方法 |
CN101569640A (zh) * | 2008-04-30 | 2009-11-04 | 浙江康恩贝健康产品有限公司 | 积雪草总苷用于制备预防或治疗妊娠纹的药物或化妆品的用途 |
CN101791283A (zh) * | 2010-02-05 | 2010-08-04 | 张德文 | 一种可消除妊娠纹和疤痕的化妆品 |
CN103006491A (zh) * | 2011-09-23 | 2013-04-03 | 深圳市金因生物技术有限公司 | 一种祛除生长纹的生物护肤制品及其制备方法 |
-
2014
- 2014-12-26 CN CN201410824539.9A patent/CN104546606B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152138A (zh) * | 2007-09-29 | 2008-04-02 | 天津盛世恒安科技发展有限公司 | 一种具有祛除妊娠纹功效的化妆制品及其制备方法 |
CN101569640A (zh) * | 2008-04-30 | 2009-11-04 | 浙江康恩贝健康产品有限公司 | 积雪草总苷用于制备预防或治疗妊娠纹的药物或化妆品的用途 |
CN101791283A (zh) * | 2010-02-05 | 2010-08-04 | 张德文 | 一种可消除妊娠纹和疤痕的化妆品 |
CN103006491A (zh) * | 2011-09-23 | 2013-04-03 | 深圳市金因生物技术有限公司 | 一种祛除生长纹的生物护肤制品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104546606A (zh) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104546606B (zh) | 一种水包油祛妊娠纹霜及其制备方法 | |
CN103251530B (zh) | 一种含有植物提取物的护肤霜 | |
CN109431829B (zh) | 一种羟基积雪草苷脂质体及其制备方法和应用 | |
CN102342993B (zh) | 一种皮肤抗敏修复外用制剂 | |
CN102406576A (zh) | 一种含有青刺果油的功效性护肤品及制备方法 | |
CN103816072A (zh) | 一种植物精粹窈窕纤体霜 | |
CN108175740A (zh) | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 | |
CN111083923A (zh) | 舒缓霜以及其制造方法 | |
CN107245394A (zh) | 一种含有鹿油火麻油的多功能冷制手工皂及其制备方法 | |
CN102978090A (zh) | 一种五子保健酒 | |
CN108158885A (zh) | 修复妊娠纹的组合物及其制备方法和应用 | |
CN108261361A (zh) | 一种含有细胞生长因子的祛痘修复膏及其制备方法 | |
CN108030754A (zh) | 一种可消除妊娠纹和淡化疤痕的护肤霜及其制备方法 | |
CN101721347A (zh) | 含人工养殖大鲵组织物或提取液的美容护肤品 | |
CN103784372A (zh) | 一种含有壳聚糖的化妆品 | |
CN109953930A (zh) | 一种具有口腔溃疡修复作用的中草药牙膏及其制备方法 | |
CN107028830A (zh) | 一种防止疤痕增生的药品及其制备工艺 | |
CN111939099A (zh) | 一种祛痘保湿面膜及其制备方法 | |
CN103356440A (zh) | 积雪草净痘祛印凝露及其制作方法 | |
CN110327264A (zh) | 有效淡化妊娠纹的配方工艺及制备方法 | |
CN106333887A (zh) | 一种具有祛痘功能的植物提取物及其制备方法与应用 | |
CN113876679B (zh) | 具有保湿和舒缓敏感肌肤的多效组合物及精华素和制备方法 | |
CN107412019A (zh) | 淡化妊娠纹的乳木果复合马油护肤品及其制备方法 | |
CN103830303B (zh) | 一种预防褥疮的组合物 | |
CN109966210B (zh) | 一种面部修护组合物、气雾剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190124 Address after: 363005 No. 8 Wuqiao North Road, Lantian Economic Development Zone, Zhangzhou City, Fujian Province Patentee after: FROG PRINCE (FUJIAN) BABY CARE PRODUCTS Co.,Ltd. Address before: 363000 Lantian Economic Development Zone, Longwen District, Zhangzhou City, Fujian Province Patentee before: Frog Prince (China) Daily Chemicals Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150429 Assignee: Fujian Herun Supply Chain Management Co.,Ltd. Assignor: FROG PRINCE (FUJIAN) BABY CARE PRODUCTS Co.,Ltd. Contract record no.: X2023980050731 Denomination of invention: A water in oil anti pregnancy wrinkle cream and its preparation method Granted publication date: 20171229 License type: Common License Record date: 20240123 |
|
EE01 | Entry into force of recordation of patent licensing contract |